Pharmacological aspects of intracerebral spasm secondary to cerebral hemorrhage. Experimental observations.
D000818:Animals; D002339:Carotid Arteries; D002533:Cerebral Angiography; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control; D005268:Femoral Vein; D000882:Haplorhini; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D011343:Procaine / Q000008:administration & dosage / Q000627:therapeutic use*; D013035:Spasm / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000000981:diagnostic imaging; D014665:Vasodilator Agents
D014665:Vasodilator Agents; D011343:Procaine; D008012:Lidocaine